The Japanese Journal of Dermatology

The Japanese Journal of Dermatology

Online ISSN : 1346-8146
Print ISSN : 0021-499X
ISSN-L : 0021-499X

Search

OR

Browse

Search

Search
Browse

All issues

Volume 128, Issue 9

Displaying 1-5 of 5 articles from this issue

Download citation

Show all abstracts

|<
<
1
>
>|

Seminar for Medical Education

[title in Japanese]

[in Japanese]

2018Volume 128Issue 9 Pages 1923-1929
Published: August 20, 2018
Released on J-STAGE: August 20, 2018

DOIhttps://doi.org/10.14924/dermatol.128.1923

JOURNAL RESTRICTED ACCESS

Show abstractHide abstract

[in Japanese]

View full abstract

Download PDF (1666K)
[title in Japanese]

[in Japanese]

2018Volume 128Issue 9 Pages 1931-1938
Published: August 20, 2018
Released on J-STAGE: August 20, 2018

DOIhttps://doi.org/10.14924/dermatol.128.1931

JOURNAL RESTRICTED ACCESS

Show abstractHide abstract

[in Japanese]

View full abstract

Download PDF (700K)
[title in Japanese]

[in Japanese]

2018Volume 128Issue 9 Pages 1939-1944
Published: August 20, 2018
Released on J-STAGE: August 20, 2018

DOIhttps://doi.org/10.14924/dermatol.128.1939

JOURNAL RESTRICTED ACCESS

Show abstractHide abstract

[in Japanese]

View full abstract

Download PDF (910K)

Original Articles

Benefits of Topical Combination Formulations of Steroid and Active Vitamin D₃ in the Treatment of Psoriasis Vulgaris-Review of the Evidence from Clinical Investigations-

Takafumi Etoh, Yayoi Tada, Shinichi Imafuku, Hidetoshi Takahashi

2018Volume 128Issue 9 Pages 1945-1956
Published: August 20, 2018
Released on J-STAGE: August 20, 2018

DOIhttps://doi.org/10.14924/dermatol.128.1945

JOURNAL RESTRICTED ACCESS

Show abstractHide abstract

Psoriasis vulgaris is managed mainly by employing topical therapies, including steroids and active vitamin D₃ formulations, which have been used for many years. Recently, topical combination formulations of steroid and active vitamin D₃ have become widely available for clinical use. We reviewed the benefits of these topical combination formulations based on evidence from clinical investigations within and outside Japan, focusing on effectiveness, economics, tolerability, patient's QOL, and adherence. Our review confirmed that topical combination formulations provide rapid efficacy, good tolerability, and improvement of patient's QOL, as well as showing the best cost-benefit performance among the topical therapies currently available. Based on our results, topical combination formulations are recommended as first-line treatment for psoriasis vulgaris.

View full abstract

Download PDF (461K)

Abstracts

[title in Japanese]

2018Volume 128Issue 9 Pages 1957-1977
Published: August 20, 2018
Released on J-STAGE: August 20, 2018

DOIhttps://doi.org/10.14924/dermatol.128.1957

JOURNAL RESTRICTED ACCESS

Download PDF (899K)

|<
<
1
>
>|

Top